- --------------------------------------------------------------------------------
- --------------------------------------------------------------------------------
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
--------------------------
FORM 10-Q/A
AMENDMENT TO FORM 10-Q QUARTERLY REPORT PURSUANT TO SECTION 13
OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.
FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 1996.
Commission File Number:
0-19731
--------------------------
GILEAD SCIENCES, INC.
(Exact name of registrant as specified in its charter)
DELAWARE 94-3047598
(State or other jurisdiction of (I.R.S. Employer
incorporation or organization) Identification No.)
353 LAKESIDE DRIVE, FOSTER CITY, CALIFORNIA 94404
(Address of principal executive offices)
(415) 574-3000
(Registrant's telephone number, including area code)
--------------------------
INDICATE BY CHECK MARK WHETHER THE REGISTRANT (1) HAS FILED ALL REPORTS
REQUIRED TO BE FILED BY SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF
1934 DURING THE PRECEDING 12 MONTHS (OR FOR SUCH SHORTER PERIOD THAT THE
REGISTRANT WAS REQUIRED TO FILE SUCH REPORTS), AND (2) HAS BEEN SUBJECT TO
FILING REQUIREMENTS FOR THE PAST 90 DAYS. YES X NO
----- -----
NUMBER OF SHARES OUTSTANDING OF THE ISSUER'S COMMON STOCK, PAR VALUE $0.001
PER SHARE, AT OCTOBER 10, 1996: 28,559,023.
- --------------------------------------------------------------------------------
- --------------------------------------------------------------------------------
EXPLANATORY NOTE
This Form 10-Q/A is being filed solely for the purpose of amending
Exhibits 10.40, 10.42, and 10.43 to the Quarterly Report on Form 10-Q for the
quarterly period ended September 30, 1996.
GILEAD SCIENCES, INC.
INDEX
PAGE NO.
PART II. OTHER INFORMATION
Item 6. Exhibits and Reports on Form 8-K . . . . . . . . . . . . . . . 4
Signature . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5
PART II. OTHER INFORMATION
ITEM 6. EXHIBITS AND REPORTS ON FORM 8-K
(a) Exhibits
EXHIBIT NUMBER DESCRIPTION
10.40+ License and Supply Agreement between Registrant and Pharmacia & Upjohn
S.A. dated August 7, 1996.
10.42+ Development and License Agreement between Registrant and F. Hoffmann-La
Roche Ltd and Hoffmann-La Roche Inc. dated September 27, 1996.
10.43+ Copromotion Agreement between Registrant and Roche Laboratories Inc.
dated September 27, 1996.
- -------------
+ The Registrant has requested confidential treatment with respect to
portions of this Exhibit.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
GILEAD SCIENCES, INC.
(Registrant)
Date: February 25, 1997 By: /s/ JOHN C. MARTIN
-----------------------
John C. Martin
President and Chief Executive Officer
(Principal Executive Officer)
Date: February 25, 1997 By: /s/ MARK L. PERRY
-----------------------
Mark L. Perry
Vice President, Chief Financial Officer
and General Counsel